A Theory-based Sleep Hygiene Education for Insomnia Patients

May 2, 2026 updated by: YEUNG Wing Fai, The Hong Kong Polytechnic University

Developing a Theory-based Sleep Hygiene Education Intervention for Insomnia Patients - A Mixed Method Study

Insomnia is a prevalent sleep disorder associated with substantial negative health consequences, including fatigue, irritability, and impaired daytime functioning. Although effective pharmacological and psychological treatments exist, fewer than half of individuals with insomnia seek professional treatment, highlighting the need for accessible and acceptable non-pharmacological interventions. Sleep hygiene education (SHE) has the potential to address this gap due to its simplicity, low cost, and ease of self-administration. However, previous studies have often underestimated the efficacy of SHE by using it as a passive control condition rather than an active, structured intervention. To address this limitation, the proposed pilot study aims to evaluate the feasibility and effectiveness of a theory-based, structured SHE program integrated with behavior change techniques.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Insomnia is a prevalent sleep disorder associated with substantial negative health consequences, including fatigue, irritability, and impaired daytime functioning. Although effective pharmacological (e.g., hypnotics) and psychological treatments (e.g., cognitive behavioral therapy for insomnia, CBT-I) are available, both local and international surveys indicate that fewer than 50% of individuals with insomnia seek treatment. This treatment gap highlights the need to develop effective non-pharmacological interventions that are both accessible and acceptable to individuals with insomnia.

Sleep hygiene education (SHE) represents a potentially suitable intervention to address this unmet need. SHE is an educational approach that encompasses a range of lifestyle and environmental recommendations aimed at optimizing sleep quality and duration, such as maintaining a regular sleep-wake schedule, avoiding substances (e.g., caffeine, nicotine, and alcohol) and daytime napping, limiting stimulating bedtime activities, creating an optimal bedroom environment, and adopting appropriate diet and exercise habits etc. Given its simplicity, low cost, accessibility, and ease of delivery and mastery, SHE holds promise as a non-pharmacological strategy for insomnia management.

Despite these advantages, SHE is not typically recommended as a stand-alone treatment for sleep-vulnerable populations, as it is often perceived to be less effective than CBT-I or mindfulness-based therapies. Notably, the efficacy of SHE may be underestimated. In many prior studies, SHE has been used primarily as a passive control condition to account for nonspecific treatment effects, resulting in its active therapeutic components being largely overlooked.

Advancing SHE beyond a simple advice-giving modality to a structured, theory-informed intervention may enhance its effectiveness by ensuring that its content is not only informative but also practicable and behaviorally achievable. Integrating SHE with evidence-based behavior change techniques may further equip participants with the skills necessary to initiate and sustain meaningful behavioral change. Accordingly, this pilot study aims to examine the feasibility and preliminary effectiveness of a theory-based SHE program previously developed by our team.

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • School of Nursing, The Hong Kong Polytechnic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hong Kong residents
  • Ethnic Chinese aged 18-65 years with the ability to communicate in Cantonese or Putonghua
  • Fulfilled the DSM-5 diagnostic criteria for insomnia disorder according to a validated diagnostic tool, the Brief Insomnia Questionnaire. The criteria included having difficulties falling asleep, staying asleep, or early morning awakening with clinically significant consequences for daily life for at least 3 months
  • Scored at least 10 points in the Insomnia Severity Index (ISI)
  • Willing to give informed consent

Exclusion Criteria:

  • Any current diagnosis fulfilling the DSM-IV criteria of a major depressive disorder, generalized anxiety disorders, post-traumatic stress disorder, panic disorder, substance use disorders, or schizophrenia as screened using the Chinese version of the Structured Clinical Interview for DSM-IV
  • Other sleep disorders, including circadian rhythm disorder, narcolepsy, obstructive sleep apnoea (OSA), and restless leg syndrome (RLS)/periodic leg movement disorder (PLMD) as determined based on cut-off scores (≥ 7 on narcolepsy; ≥ 8 on circadian rhythm disorder; ≥ 15 on OSA; ≥ 7 on RLS/PLMD) using SLEEP-50. If in doubt, subjects will be referred to our team psychiatrist (KF Chung) for further assessment
  • Any current medical conditions or side-effects of medication that are contributing significantly to the subject's insomnia
  • Taking medications or currently participating in other psychotherapies for insomnia or other psychiatric disorders
  • Impaired cognitive functioning (<22 points in HK-MoCA) or with difficulty in giving consent or understanding instructions
  • Pregnant
  • Shift work

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sleep Hygiene Education

Participants in this group will receive a structured six-week SHE intervention. The intervention includes two weekly 2 hours group-based, face-to-face educational sessions (total 4 hours) conducted in a classroom at the School of Nursing, The Hong Kong Polytechnic University, followed by four weekly individualized telephone consultations lasting approximately 10 minutes each.

During the educational sessions, participants will receive education on insomnia and evidence-based sleep hygiene practices and will develop individualized behavior change plans to support sustained sleep hygiene implementation. The subsequent telephone consultations will reinforce adherence to these plans through review of progress, discussion of barriers, and provision of tailored feedback.

To obtain qualitative feedback on the acceptability of the intervention, a focus group interview lasting approximately 1 hour will be conducted after completion of the second educational session.

Participants in this group will receive a structured six-week SHE intervention. The intervention includes two weekly 2 hours group-based, face-to-face educational sessions (total 4 hours) conducted in a classroom at the School of Nursing, The Hong Kong Polytechnic University, followed by four weekly individualized telephone consultations lasting approximately 10 minutes each.

During the educational sessions, participants will receive education on insomnia and evidence-based sleep hygiene practices and will develop individualized behavior change plans to support sustained sleep hygiene implementation. The subsequent telephone consultations will reinforce adherence to these plans through review of progress, discussion of barriers, and provision of tailored feedback.

To obtain qualitative feedback on the acceptability of the intervention, a focus group interview lasting approximately 1 hour will be conducted after completion of the second educational session.

Other Names:
  • SHE

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Insomnia Severity Index (ISI)
Time Frame: Baseline, week 6
The Insomnia Severity Index has 7 items that measured the severity of insomnia complaints and related daytime impairments. The total score ranges between 0 and 28, with the higher scores indicating more severe insomnia. Total score will be used.
Baseline, week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A 7-day Subjective Sleep Diary
Time Frame: 7-day before baseline and 6 week.
The subjects will be asked to record their daily sleeping-waking schedule using a standard sleep diary for 7 days, and Sleep parameters, such as sleep onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE), and sleep duration (TST) will be measured.
7-day before baseline and 6 week.
Course Evaluation Form
Time Frame: Week 2
Participants will be asked to complete a course evaluation form after completing the two SHE sessions. The evaluation consists of five domains comprising a total of 28 items, each rated on a 5-point Likert scale. Total scores range from 28 to 140, with higher scores indicating greater satisfaction with the course content and educational materials.
Week 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 10, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

April 23, 2026

First Submitted That Met QC Criteria

April 23, 2026

First Posted (Actual)

April 30, 2026

Study Record Updates

Last Update Posted (Actual)

May 7, 2026

Last Update Submitted That Met QC Criteria

May 2, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia

Clinical Trials on Sleep Hygiene Education

Subscribe